NEW YORK (GenomeWeb) - WaferGen Bio-systems reported after the close of the market on Tuesday that its second quarter revenues rose 56 percent, driven by an increase in product revenues.

For the three months ended June 30, the company reported revenues of $2.5 million, up from $1.6 million in the prior-year period. Product revenues accounted for all recorded revenues, rising 70 percent, primarily attributable to increases in sales of its SmartChip NGS target enrichment system. The firm did not record any license and royalty revenue in the quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.